NRG Therapeutics
Agent25Agent Readiness: 25/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
We may earn a commission from links on this NRG Therapeutics profile. That does not change the facts we publish.
About
NRG Therapeutics is a biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's. Their approach centers on restoring mitochondrial function, a key factor in the progression of these debilitating conditions.
Similar companies
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Shares Biotech, MedTech
A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Shares Biotech, MedTech
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Shares Biotech, Drug Discovery
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Shares Biotech, Pharmaceuticals
Key facts
- Website
- nrgtherapeutics.com
- Headquarters
- Stevenage, United Kingdom
- Employees
- 23
- Total funding
- $59M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 8 Sept 2025 | Series B | $50M | Brandon Capital, Dementia Discovery Fund (DDF) |
| 23 Jan 2024 | Undisclosed round | $2M | |
| 24 Jan 2023 | Undisclosed round | $2M | |
| 25 Jan 2022 | Undisclosed round | $2M | |
| 26 Jan 2021 | Undisclosed round | $2M | |
| 28 Jan 2020 | Undisclosed round | $3M |
Tech stack
Detected on nrgtherapeutics.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- jQuery
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
- Cookie consent
- Cookiebot
- Affiliate program
- Self-hosted affiliate
NRG Therapeutics scores 28. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is NRG Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for NRG Therapeutics is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has NRG Therapeutics raised?
NRG Therapeutics has raised a total of $59M in funding. The most recent round on record is Series B.
How many employees does NRG Therapeutics have?
NRG Therapeutics has approximately 23 people on record.
Does NRG Therapeutics have an affiliate program?
Yes, NRG Therapeutics has an affiliate program. The program runs on Self-hosted affiliate. Register here: nrgtherapeutics.com/affiliates
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for NRG Therapeutics
